GSK hasn’t got anything similar to Opdivo or Keytruda on the market atm.. Looking more like behind the pack atm !
I often wonder what GSK is focusing on new development drugs or cancer treatment therapy ?
Wherether using our IMP321 as the main compound in combination with chemotherapeutic treatment ?
Right to Try Legislation in the USA., page-4
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
-0.005(1.10%) |
Mkt cap ! $534.9M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 44.0¢ | $427.7K | 957.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 113181 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 173394 | 4 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
44.5¢ |
Change
-0.005 ( 2.13 %) |
||||
| Open | High | Low | Volume | ||
| 45.0¢ | 45.0¢ | 44.0¢ | 210362 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| IMM (ASX) Chart |